Sagittarius Life Science Corp (TPEX:3205)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
50.50
+2.50 (5.21%)
At close: Feb 11, 2026
Market Cap3.41B +203.8%
Revenue (ttm)424.44M -6.8%
Net Income-46.33M
EPS-1.02
Shares Out67.55M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume234,295
Average Volume176,564
Open49.45
Previous Close48.00
Day's Range48.65 - 50.90
52-Week Range21.30 - 61.60
Beta0.77
RSI56.16
Earnings DateMar 27, 2026

About Sagittarius Life Science

Sagittarius Life Science Corp engages in the research, development, and sale of Chinese and western medicines, and health food products in Taiwan and Asia. It also offers organic food, daily necessities, and pet food; and engages in the research and development of biotechnology. Sagittarius Life Science Corp was founded in 1998 and is based in Taipei, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1998
Employees 112
Stock Exchange Taipei Exchange
Ticker Symbol 3205
Full Company Profile

Financial Performance

In 2024, Sagittarius Life Science's revenue was 467.75 million, an increase of 6.20% compared to the previous year's 440.46 million. Losses were -48.53 million, -11.82% less than in 2023.

Financial Statements